Paloma Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,060
| Closed | -$95.5K | – | 212 |
|
|
2024
Q4 | $95.5K | Buy |
+1,060
| New | +$95.5K | ﹤0.01% | 184 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1253 |
|
|
2023
Q3 | – | Sell |
-14,928
| Closed | -$1.24M | – | 427 |
|
|
2023
Q2 | $1.24M | Buy |
14,928
+1,280
| +9% | +$106K | 0.04% | 75 |
|
|
2023
Q1 | $1.04M | Buy |
+13,648
| New | +$1.04M | 0.04% | 65 |
|
|
2022
Q1 | – | Sell |
-22,270
| Closed | -$2.49M | – | 1792 |
|
|
2021
Q4 | $2.49M | Buy |
+22,270
| New | +$2.49M | 0.04% | 282 |
|
|
2017
Q2 | – | Sell |
-42,137
| Closed | -$2.92M | – | 1880 |
|
|
2017
Q1 | $2.92M | Buy |
42,137
+7,137
| +20% | +$495K | 0.04% | 301 |
|
|
2016
Q4 | $2.07M | Buy |
+35,000
| New | +$2.07M | 0.02% | 394 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 1903 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 1681 |
|